ArticlePharmaceutical research2026

High-Dose Sunitinib Accelerates Triple-Negative Breast Cancer Metastasis by Modulating an Immunosuppressive Microenvironment: A Preclinical 4T1 Model Study.

Chen Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.